RIL
SLNO

Rothschild Investment LLC’s Soleno Therapeutics SLNO Stock Holding History

Rothschild Investment LLC’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-47
Closed -$1.57K – 3708
2026
Q1 		$1.57K Buy
47
+18
+62% +$706 ﹤0.01% 2662
2025
Q4 		$1.34K Sell
29
-11
-28% -$603 ﹤0.01% 2560
2025
Q3 		$2.7K Sell
40
-35
-47% -$2.6K ﹤0.01% 2036
2025
Q2 		$6.28K Buy
75
+30
+67% +$2.25K ﹤0.01% 1394
2025
Q1 		$3.21K Buy
45
+25
+125% +$1.22K ﹤0.01% 1646
2024
Q4 		$899 Hold
20
– – ﹤0.01% 2274
2024
Q3 		$1.01K Buy
20
+15
+300% +$718 ﹤0.01% 2163
2024
Q2 		$204 Buy
+5
New +$212 ﹤0.01% 2482

Rothschild Investment LLC's SLNO Position: Q2 2026 in Review

Rothschild Investment LLC sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 47 shares — an estimated $1.57K sold.

Rothschild Investment LLC first reported a position in SLNO in Q2 2024 and held it in 8 quarters. The position peaked at $6.28K in Q2 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

  • Rothschild Investment LLC reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Rothschild Investment LLC sold 47 Soleno Therapeutics shares in Q2 2026, an estimated $1.57K.
  • Rothschild Investment LLC first reported a position in Soleno Therapeutics in Q2 2024 and held it in 8 quarters.
  • Rothschild Investment LLC's Soleno Therapeutics position peaked at $6.28K in Q2 2025.
  • 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.